LMC|Manna Research’s President, Ms. Karri Venn, we be at the 2018 ATTD (Advance Technologies and Treatment for Diabetes) Conference on the 14-17th of February in Vienna, Austria.
We are in the midst of forming strategic partnerships to help your trials become more efficient; help speed up start up timelines by negotiating one contract for all sites, using a central IRB, streamlining innovative recruiting initiatives such as patient & community engagement, and consistently providing quality data.
Ms. Venn would be delighted to further explain in detail about LMC|Manna Research during her time at 2018 ATTD. Please contact Ms. Venn directly at the information below to schedule a meeting during her time at the 2018 ATTD Conference in Vienna.
During your time at ATTD 2018, make sure to also come and see LMC’s very own Dr. Abitbol present findings from his abstract: “LONGEVITY OF AN IMPLANTABLE CGM SYSTEM DURING A 180 DAY STUDY”.